Keyword Connections

aflibercept

Journals

1

1 Frontiers in medicine

Research Groups

0

No Research Group Connected

Bibliographies

10

1 Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation.

2 Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

3 Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

4 Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

5 Targeting galectin-1 by aflibercept strongly enhances its antitumor effect in neuroendocrine carcinomas.

6 successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

7 antiproliferative, apoptotic, and autophagic activity of ranibizumab, bevacizumab, pegaptanib, and aflibercept on fibroblasts: implication for choroidal neovascularization

8 conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

9 ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance

10 comparisons of efficacy of intravitreal aflibercept and ranibizumab in eyes with diabetic macular edema